Terms: = Liver cancer AND B2M, P61769, 567, ENSG00000166710 AND Prognosis
19 results:
1. Applying image features of proximal paracancerous tissues in predicting prognosis of patients with hepatocellular carcinoma.
Lin S; Yong J; Zhang L; Chen X; Qiao L; Pan W; Yang Y; Zhao H
Comput Biol Med; 2024 May; 173():108365. PubMed ID: 38537563
[TBL] [Abstract] [Full Text] [Related]
2. [Efficacy, prognosis and influencing factors of transcatheter arterial embolization in the treatment of neuroendocrine neoplasm liver metastases].
Zhang Y; Xu RT; Bai JA; Hu P; Li XY; Tian Y; Tang QY
Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(37):2952-2958. PubMed ID: 37752055
[No Abstract] [Full Text] [Related]
3. Main causes of death in advanced biliary tract cancer.
Kimura-Seto K; Kojima Y; Komori S; Hisada Y; Otake Y; Yanai Y; Saito A; Akazawa N; Tanaka Y; Yokoi C; Yanase M; Akiyama J; Yamamoto N; Yamada K
Cancer Med; 2023 May; 12(9):10889-10898. PubMed ID: 36991582
[TBL] [Abstract] [Full Text] [Related]
4. [Comparison of follow-up treatment regimens for colorectal cancer liver metastases without objective response to neoadjuvant chemotherapy: direct surgery or surgery after second-line chemotherapy].
Lyu XY; Bi XY; Zhao H; Chen QC; Luo ZW; Zhang BL; Zhang XS; Cai JQ
Zhonghua Wai Ke Za Zhi; 2022 May; 60(5):454-460. PubMed ID: 35359087
[No Abstract] [Full Text] [Related]
5. Double-Negative α-Fetoprotein and Carbohydrate Antigen 19-9 Predict a Good prognosis in Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis.
Zhang X; Zhou Y; Wu Z; Peng W; Li C; Yan L; Yang J; Wen T
Clin Transl Gastroenterol; 2021 Nov; 12(11):e00425. PubMed ID: 34751187
[TBL] [Abstract] [Full Text] [Related]
6. Treatment strategy for resectable colorectal cancer liver metastases from the viewpoint of time to surgical failure.
Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K
Langenbecks Arch Surg; 2022 Mar; 407(2):699-706. PubMed ID: 34741671
[TBL] [Abstract] [Full Text] [Related]
7. PTEN Loss as a Predictor of Tumor Heterogeneity and Poor prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung cancer Receiving Tyrosine Kinase Inhibitors.
Ferrara MG; Martini M; D'Argento E; Forcella C; Vita E; Di Noia V; Sperduti I; Bilotta M; Ribelli M; Damiano P; Cannella A; Stefani A; Pilotto S; Carbone C; Piro G; Milella M; Tortora G; Bria E
Clin Lung Cancer; 2021 Jul; 22(4):351-360. PubMed ID: 33558194
[TBL] [Abstract] [Full Text] [Related]
8. Validation of common reference genes stability in exosomal mRNA-isolated from liver and breast cancer cell lines.
Gorji-Bahri G; Moradtabrizi N; Vakhshiteh F; Hashemi A
Cell Biol Int; 2021 May; 45(5):1098-1110. PubMed ID: 33501690
[TBL] [Abstract] [Full Text] [Related]
9. Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.
Hiraoka A; Kumada T; Atsukawa M; Hirooka M; Tsuji K; Ishikawa T; Takaguchi K; Kariyama K; Itobayashi E; Tajiri K; Shimada N; Shibata H; Ochi H; Tada T; Toyoda H; Nouso K; Tsutsui A; Nagano T; Itokawa N; Hayama K; Imai M; Joko K; Tanaka H; Tamai T; Koizumi Y; Hiasa Y; Michitaka K; Kudo M; ;
Oncology; 2019; 97(5):277-285. PubMed ID: 31307035
[TBL] [Abstract] [Full Text] [Related]
10. Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy.
Hamfjord J; Guren TK; Dajani O; Johansen JS; Glimelius B; Sorbye H; Pfeiffer P; Lingjærde OC; Tveit KM; Kure EH; Pallisgaard N; Spindler KG
Ann Oncol; 2019 Jul; 30(7):1088-1095. PubMed ID: 31046124
[TBL] [Abstract] [Full Text] [Related]
11. [prognosis of Conversion Gastrectomy Cases for Stage IV Gastric cancer].
Ohnishi T; Kinami S; Fujii Y; Miura S; Fujita J; Kaida D; Tomita Y; Fujita H; Nakano Y; Ueda N; Kosaka T
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1799-1801. PubMed ID: 29394780
[TBL] [Abstract] [Full Text] [Related]
12. Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases.
Izumoto H; Hiraoka A; Ishimaru Y; Murakami T; Kitahata S; Ueki H; Aibiki T; Okudaira T; Miyamoto Y; Yamago H; Iwasaki R; Tomida H; Mori K; Kishida M; Tsubouchi E; Miyata H; Ninomiya T; Kawasaki H; Hirooka M; Matsuura B; Abe M; Hiasa Y; Michitaka K; Kudo M
Oncology; 2017; 93 Suppl 1():120-126. PubMed ID: 29258105
[TBL] [Abstract] [Full Text] [Related]
13. The Prediction of Clinical Outcome in Hepatocellular Carcinoma Based on a Six-Gene Metastasis Signature.
Yuan S; Wang J; Yang Y; Zhang J; Liu H; Xiao J; Xu Q; Huang X; Xiang B; Zhu S; Li L; Liu J; Liu L; Zhou W
Clin Cancer Res; 2017 Jan; 23(1):289-297. PubMed ID: 27449498
[TBL] [Abstract] [Full Text] [Related]
14. dbPHCC: a database of prognostic biomarkers for hepatocellular carcinoma that provides online prognostic modeling.
Ouyang J; Sun Y; Li W; Zhang W; Wang D; Liu X; Lin Y; Lian B; Xie L
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2688-95. PubMed ID: 26940364
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study.
Pidala J; Chai X; Kurland BF; Inamoto Y; Flowers ME; Palmer J; Khera N; Jagasia M; Cutler C; Arora M; Vogelsang G; Lee SJ
Biol Blood Marrow Transplant; 2013 May; 19(5):784-91. PubMed ID: 23395601
[TBL] [Abstract] [Full Text] [Related]
16. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
[TBL] [Abstract] [Full Text] [Related]
17. Role of tissue factor in hepatocellular carcinoma genesis, invasion and metastasis.
Zhou Q; Huang T; Wang YF; Zhou XB; Liang LJ; Peng BG
Chin Med J (Engl); 2011 Nov; 124(22):3746-51. PubMed ID: 22340235
[TBL] [Abstract] [Full Text] [Related]
18. The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy.
Suzuki C; Blomqvist L; Sundin A; Jacobsson H; Byström P; Berglund Å; Nygren P; Glimelius B
Ann Oncol; 2012 Apr; 23(4):948-54. PubMed ID: 21832285
[TBL] [Abstract] [Full Text] [Related]
19. [The changes in copper contents and its clinical significance in patients with liver cirrhosis and hepatocarcinoma].
Zhang YJ; Zhao DH; Huang CX
Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):113-6. PubMed ID: 8070291
[TBL] [Abstract] [Full Text] [Related]
